A Nonradioisotope Biomedical Assay for Intact Oligonucleotide and Its Chain-Shortened Metabolites Used for Determination of Exposure and Elimination Half-Life of Antisense Drugs in Tissue

This publication has 14 references indexed in Scilit:

• Pharmacokinetics, metabolism, and elimination of a 20-mer phosphorothioate oligodeoxynucleotide (cgp 69846a) after intravenous and subcutaneous administration
  Published by Elsevier ,1998
• Histological Localization of Phosphorothioate Oligodeoxynucleotides in Normal Rodent Tissue
  Nucleosides and Nucleotides, 1997
• Characterization of Oligonucleotide MetabolismIn Vivovia Liquid Chromatography/Electrospray Tandem Mass Spectrometry with a Quadrupole Ion Trap Mass Spectrometer
  Journal of Mass Spectrometry, 1997
• On-Line HPLC Electrospray Mass Spectrometry of Phosphorothioate Oligonucleotide Metabolites
  Analytical Chemistry, 1997
• Definition by specific antisense oligonucleotides of a role for protein kinase Cα in expression of differentiation markers in normal and neoplastic mouse epidermal keratinocytes
  Molecular Carcinogenesis, 1997
• Quantitation of Phosphorothioate Oligonucleotides in Human Plasma
  Analytical Biochemistry, 1996
• Transport of phosphorothioate oligonucleotides in kidney: Implications for molecular therapy
  Kidney International, 1995
• Renal Disposition Characteristics of Oligonucleotides Modified at Terminal Linkages in the Perfused Rat Kidney
  Antisense Research and Development, 1995
• Pharmacokinetics of Antisense Oligonucleotides
  Clinical Pharmacokinetics, 1995
• Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.
  Proceedings of the National Academy of Sciences, 1991